VEA

Virtus ETF Advisers Portfolio holdings

AUM $75.7M
1-Year Return 23.01%
This Quarter Return
-0.88%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$227M
AUM Growth
-$15.9M
Cap. Flow
-$6.79M
Cap. Flow %
-2.99%
Top 10 Hldgs %
7.9%
Holding
407
New
8
Increased
60
Reduced
329
Closed
10

Top Buys

1
XFLT
XAI Octagon Floating Rate and Alternative Income Trust
XFLT
$663K
2
VTA
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
$551K
3
FRA icon
BlackRock Floating Rate Income Strategies Fund
FRA
$469K
4
EFT
Eaton Vance Floating-Rate Income Trust
EFT
$425K
5
ENIC icon
Enel Chile
ENIC
$406K

Top Sells

1
GRA
W.R. Grace & Co.
GRA
$1.73M
2
BGX
Blackstone Long-Short Credit Income Fund
BGX
$731K
3
BGB
Blackstone Strategic Credit 2027 Term Fund
BGB
$693K
4
NOA
North American Construction
NOA
$569K
5
MCI
Barings Corporate Investors
MCI
$524K

Sector Composition

1 Healthcare 25.28%
2 Real Estate 19.7%
3 Energy 13.28%
4 Utilities 12%
5 Materials 10.51%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BLW icon
151
BlackRock Limited Duration Income Trust
BLW
$548M
$463K 0.2%
27,120
+624
+2% +$10.7K
CERE
152
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$462K 0.2%
15,667
-817
-5% -$24.1K
GAIN icon
153
Gladstone Investment Corp
GAIN
$542M
$460K 0.2%
33,138
-3,812
-10% -$52.9K
VVR icon
154
Invesco Senior Income Trust
VVR
$553M
$457K 0.2%
102,698
-2,381
-2% -$10.6K
DVAX icon
155
Dynavax Technologies
DVAX
$1.18B
$453K 0.2%
23,572
-1,227
-5% -$23.6K
KDMN
156
DELISTED
Kadmon Holdings, Inc.
KDMN
$448K 0.2%
51,476
-2,686
-5% -$23.4K
NBIX icon
157
Neurocrine Biosciences
NBIX
$14.3B
$441K 0.19%
4,594
-418
-8% -$40.1K
MAIN icon
158
Main Street Capital
MAIN
$5.93B
$437K 0.19%
10,643
-610
-5% -$25K
EVF
159
Eaton Vance Senior Income Trust
EVF
$101M
$434K 0.19%
61,624
-492
-0.8% -$3.47K
DCPH
160
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$431K 0.19%
12,686
-1,160
-8% -$39.4K
HALO icon
161
Halozyme
HALO
$8.64B
$429K 0.19%
10,551
-964
-8% -$39.2K
BMRN icon
162
BioMarin Pharmaceuticals
BMRN
$11B
$428K 0.19%
5,544
-510
-8% -$39.4K
VRTX icon
163
Vertex Pharmaceuticals
VRTX
$101B
$426K 0.19%
2,350
-213
-8% -$38.6K
CLDX icon
164
Celldex Therapeutics
CLDX
$1.53B
$425K 0.19%
7,865
-435
-5% -$23.5K
EFT
165
Eaton Vance Floating-Rate Income Trust
EFT
$319M
$425K 0.19%
+29,196
New +$425K
EXEL icon
166
Exelixis
EXEL
$10.1B
$425K 0.19%
20,097
-1,840
-8% -$38.9K
INSM icon
167
Insmed
INSM
$30.4B
$420K 0.18%
15,261
-1,399
-8% -$38.5K
QNCX icon
168
Quince Therapeutics
QNCX
$85.4M
$410K 0.18%
4,474
-229
-5% -$21K
FOLD icon
169
Amicus Therapeutics
FOLD
$2.52B
$407K 0.18%
42,669
-3,907
-8% -$37.3K
IONS icon
170
Ionis Pharmaceuticals
IONS
$9.88B
$406K 0.18%
12,102
-1,110
-8% -$37.2K
OMER icon
171
Omeros
OMER
$285M
$406K 0.18%
29,436
-2,694
-8% -$37.2K
VNDA icon
172
Vanda Pharmaceuticals
VNDA
$273M
$406K 0.18%
23,693
-2,177
-8% -$37.3K
BCRX icon
173
BioCryst Pharmaceuticals
BCRX
$1.74B
$404K 0.18%
28,090
-2,579
-8% -$37.1K
AMGN icon
174
Amgen
AMGN
$152B
$402K 0.18%
1,891
-179
-9% -$38.1K
RARE icon
175
Ultragenyx Pharmaceutical
RARE
$3.07B
$401K 0.18%
4,450
-403
-8% -$36.3K
5 6
7
8 9